Treatment outcomes of small cell carcinoma of the prostate

The current study was conducted to determine the clinical characteristics and prognostic features associated with prostatic small cell carcinoma (SCC).

[1]  R. Millikan,et al.  Prostate cancer progression in the presence of undetectable or low serum prostate‐specific antigen level , 2007, Cancer.

[2]  M. Oya,et al.  Clinicopathological Features Predicting Nodal Metastasis of Testicular Seminoma: Results from 100 Cases in a Single Institute , 2006, Urologia Internationalis.

[3]  P. Russo,et al.  Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  A. Soran,et al.  Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma? , 2006, Medical science monitor : international medical journal of experimental and clinical research.

[5]  R. Millikan,et al.  1240: Prospective Evidence Supporting the Utility of Neooadjuvant Chemotherapy in Small Cell Urothelial Cancer: Preliminary Results from A Phase II Clinical Trial at the M.D. Anderson Cancer Center , 2006 .

[6]  S. Dahrouge,et al.  Genitourinary small cell carcinoma: a retrospective review of treatment and survival patterns at The Ottawa Hospital Regional Cancer Center , 2006, BJU international.

[7]  R. Millikan,et al.  Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. , 2004, The Journal of urology.

[8]  H. Kung,et al.  Angiogenesis is not Mediated by Prostate Cancer Neuropeptides , 2004, Angiogenesis.

[9]  P. Thall,et al.  Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  F. Tas,et al.  Serum Lactate Dehydrogenase Levels at Presentation Predict Outcome of Patients With Limited‐Stage Small‐Cell Lung Cancer , 2001, American journal of clinical oncology.

[11]  A. Psyrri,et al.  Small cell lung cancer: strategies to optimize chemotherapy response. , 2001, Cancer journal.

[12]  J. Köllermann,et al.  Neuroendocrine Differentiation in Prostatic Carcinomas: Histogenesis, Biology, Clinical Relevance, and Future Therapeutical Perspectives , 1999, Urologia Internationalis.

[13]  P. Blitzer,et al.  Small cell anaplastic carcinoma of the prostate: seven new cases, review of the literature, and discussion of a therapeutic strategy. , 1997, American journal of clinical oncology.

[14]  P. Bunn,et al.  Overview of chemotherapy for small cell lung cancer. , 1997, Seminars in oncology.

[15]  C. Logothetis,et al.  Chemotherapy for small cell carcinoma of prostatic origin. , 1992, The Journal of urology.

[16]  J. Oesterling,et al.  Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients. , 1992, The Journal of urology.

[17]  F. Johnson,et al.  Small cell carcinoma of the prostate , 1991, Cancer.

[18]  C. Logothetis,et al.  Small cell carcinoma of the prostate part I a clinicopathologic study of 20 cases , 1987, Cancer.

[19]  G. Mendelsohn,et al.  The histogenesis of small cell carcinoma of the prostate an immunohistochemical study , 1984, Cancer.

[20]  A. Pearse,et al.  Embryology of the diffuse neuroendocrine system and its relationship to the common peptides. , 1979, Federation proceedings.

[21]  R. Wenk,et al.  Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia , 1977, Cancer.

[22]  D. Evans,et al.  Argentaffin cells in prostatic carcinoma: Differentiation from lipofuscin and melanin in prostatic epithelium , 1971, The Journal of pathology.

[23]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .